News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
673,636 Results
Type
Article (62820)
Company Profile (80)
Press Release (610718)
Multimedia
Podcasts (117)
Webinars (22)
Section
Business (174371)
Career Advice (2764)
Deals (32577)
Drug Delivery (129)
Drug Development (77222)
Employer Resources (155)
FDA (15235)
Job Trends (14002)
News (306405)
Policy (29200)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2948)
Academic (2)
Accelerated approval (44)
Adcomms (30)
Allergies (169)
Alliances (43336)
ALS (200)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (412)
Approvals (15614)
Artificial intelligence (646)
Autoimmune disease (266)
Automation (50)
Bankruptcy (291)
Best Places to Work (10870)
BIOSECURE Act (16)
Biosimilars (202)
Biotechnology (58)
Bladder cancer (182)
Brain cancer (74)
Breast cancer (709)
Cancer (5553)
Cardiovascular disease (447)
Career advice (2365)
Career pathing (46)
CAR-T (324)
CDC (55)
Celiac Disease (3)
Cell therapy (872)
Cervical cancer (44)
Clinical research (67049)
Collaboration (1967)
Company closure (7)
Compensation (827)
Complete response letters (80)
COVID-19 (2710)
CRISPR (107)
C-suite (1133)
Cystic fibrosis (150)
Data (7416)
Decentralized trials (3)
Denatured (47)
Depression (160)
Dermatology (69)
Diabetes (542)
Diagnostics (6677)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (306)
Drug pricing (201)
Drug shortages (28)
Duchenne muscular dystrophy (251)
Earnings (64416)
Editorial (67)
Employer branding (18)
Employer resources (139)
Events (100293)
Executive appointments (1126)
FDA (18844)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (32)
Funding (1664)
Gene editing (232)
Generative AI (56)
Gene therapy (660)
GLP-1 (982)
Government (4777)
Grass and pollen (7)
Guidances (399)
Healthcare (18376)
HIV (77)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (250)
Immuno-oncology (83)
Indications (165)
Infectious disease (3028)
Inflammatory bowel disease (206)
Inflation Reduction Act (13)
Influenza (131)
Intellectual property (281)
Interviews (534)
IPO (14927)
IRA (45)
Job creations (3436)
Job search strategy (1952)
JPM (64)
Kidney cancer (19)
Labor market (84)
Layoffs (602)
Leadership (43)
Legal (6501)
Liver cancer (91)
Longevity (28)
Lung cancer (726)
Lymphoma (409)
Machine learning (55)
Management (54)
Manufacturing (921)
MASH (181)
Medical device (13170)
Medtech (13263)
Mergers & acquisitions (18912)
Metabolic disorders (1401)
mRNA (201)
Multiple sclerosis (173)
NASH (14)
Neurodegenerative disease (384)
Neuropsychiatric disorders (101)
Neuroscience (3125)
Neurotech (1)
NextGen: Class of 2026 (6399)
Non-profit (4395)
Now hiring (26)
Obesity (636)
Opinion (314)
Ovarian cancer (203)
Pain (248)
Pancreatic cancer (286)
Parkinson's disease (344)
Partnered (33)
Patents (581)
Patient recruitment (664)
Peanut (62)
People (61857)
Pharmaceutical (18)
Pharmacy benefit managers (29)
Phase 1 (21130)
Phase 2 (29587)
Phase 3 (21563)
Pipeline (7737)
Policy (301)
Postmarket research (2473)
Preclinical (9016)
Press Release (67)
Prostate cancer (294)
Psychedelics (46)
Radiopharmaceuticals (312)
Rare diseases (1004)
Real estate (6061)
Recruiting (67)
Regulatory (23047)
Reports (43)
Research institute (2494)
Resumes & cover letters (411)
Rett syndrome (37)
RNA editing (20)
RSV (75)
Schizophrenia (172)
Series A (281)
Series B (198)
Service/supplier (8)
Sickle cell disease (107)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (47)
Startups (3406)
State (1)
Stomach cancer (12)
Supply chain (105)
Tariffs (70)
The Weekly (67)
Vaccines (1044)
Venture capital (93)
Weight loss (401)
Women's health (108)
Worklife (23)
Date
Today (36)
Last 7 days (712)
Last 30 days (2577)
Last 365 days (28557)
2026 (9993)
2025 (28682)
2024 (32287)
2023 (36345)
2022 (46643)
2021 (51602)
2020 (50762)
2019 (44827)
2018 (34115)
2017 (30727)
2016 (30086)
2015 (35461)
2014 (28411)
2013 (24965)
2012 (26237)
2011 (26493)
2010 (24974)
Location
Africa (890)
Alabama (92)
Alaska (6)
Arizona (271)
Arkansas (16)
Asia (39789)
Australia (7154)
California (11734)
Canada (3422)
China (1241)
Colorado (503)
Connecticut (505)
Delaware (378)
Europe (92970)
Florida (1769)
Georgia (400)
Hawaii (3)
Idaho (61)
Illinois (1028)
India (86)
Indiana (539)
Iowa (23)
Japan (489)
Kansas (122)
Kentucky (48)
Louisiana (40)
Maine (78)
Maryland (1414)
Massachusetts (8236)
Michigan (367)
Minnesota (628)
Mississippi (7)
Missouri (152)
Montana (35)
Nebraska (27)
Nevada (129)
New Hampshire (82)
New Jersey (3253)
New Mexico (30)
New York (3209)
North Carolina (1563)
North Dakota (10)
Northern California (5784)
Ohio (366)
Oklahoma (26)
Oregon (43)
Pennsylvania (2297)
Puerto Rico (28)
Rhode Island (48)
South America (1206)
South Carolina (67)
South Dakota (2)
Southern California (4704)
Tennessee (199)
Texas (1921)
United States (41990)
Utah (364)
Vermont (1)
Virginia (299)
Washington D.C. (67)
Washington State (959)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
673,636 Results for "university of rhode island".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
April 21, 2026
·
1 min read
Press Releases
MindImmune Awarded Grant to Accelerate IND-Enabling Studies through Rhode Island Life Science Hub
June 4, 2025
·
2 min read
Layoffs
After Axing Diabetes Asset, Vertex Lays Off 140 Staff
The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into one.
June 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Manufacturing
As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
February 3, 2026
·
4 min read
·
Nick Paul Taylor
Policy
Teva, Allergan Reach Opioid Settlement Agreement with Rhode Island
Teva Pharmaceuticals and AbbVie will pay the state of Rhode Island a combined $28.5 million to settle opioid-related claims against the companies.
March 22, 2022
·
3 min read
·
Alex Keown
Business
Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors
Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health, today announced the appointment of Linda Rhodes, VMD, PhD to its Board of Directors.
June 17, 2024
·
3 min read
Press Releases
IGC Pharma Expands CALMA Phase 2 Trial to Island Health’s Royal Jubilee Hospital in Canada
September 3, 2025
·
4 min read
Policy
Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states
The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB, Clinical Laboratory licensure, allowing physicians in Rhode Island to order the IMMray™ PanCan-d test for their patients.
May 17, 2022
·
2 min read
Business
Nodexus Names William Rhodes Executive Chairman of the Board
Nodexus Inc. today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors.
March 18, 2024
·
2 min read
1 of 67,364
Next
